Wednesday, January 19, 2022

UOH startup

UoH Startup and INDRAS research proposes drug for Covid-19 treatment

The first result offering a safe, ready-to-use and cost-effective solution for Covid-19 treatment, Ertugliflozin is an FDA approved drug for type-2 diabetes.

UOH startup develops new technology to make Favipiravir

The developed synthetic process technology is cost effective and eco-friendly which uses less solvents and easy to isolate the target molecule in large quantities

Latest News

- Advertisement -